We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main analysis. The VE was 62% (95% CI: 45–74) for one dose only and 89% (95% CI: 79–94) for complete vaccination. COVID-19 vaccines provide good protection against COVID-19 presentation at primary care/outpatient level, particularly among fully vaccinated individuals.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Europe, vaccine effectiveness, multicentre study, test-negative design, 【초록키워드】 COVID-19 vaccine, vaccination, Effectiveness, Control, multicentre, dose, vaccinated individuals, symptomatic SARS-CoV-2 infection, Complete, European, main analysis, eight, 【제목키워드】 Effectiveness, Older, symptomatic SARS-CoV-2 infection,
【저자키워드】 COVID-19, SARS-CoV-2, Europe, vaccine effectiveness, multicentre study, test-negative design, 【초록키워드】 COVID-19 vaccine, vaccination, Effectiveness, Control, multicentre, dose, vaccinated individuals, symptomatic SARS-CoV-2 infection, Complete, European, main analysis, eight, 【제목키워드】 Effectiveness, Older, symptomatic SARS-CoV-2 infection,